US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

108.98

+2.081.94%

Post-market: 108.980.00000.00%16:10 EDT

Volume:7K

Turnover:717.34K

Market Cap:119.88M

PE:- -

High:109.26

Open:108.98

Low:108.82

Close:106.91

52wk High:109.95

52wk Low:66.88

Shares:1.10M

Float Shares:1.10M

Volume Ratio:0.61

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ImageneBio appoints Matt Robbins as general counsel

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

Novartis agrees to acquire Myricx Bio for up to $1.5B

Bio-Gene Technology to Hold Virtual Extraordinary General Meeting in August

How FDA Priority Review for First-in-Class LGMD Drug BBP-418 Could Impact BridgeBio Pharma (BBIO) Investors

Simply Wall St.

Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data

BridgeBio Wins FDA Priority Review for BBP-418 Therapy

BridgeBio announces FDA acceptance, priority review of BBP-418 NDA

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

BridgeBio submits BBP-418 NDA to FDA

BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9

Solana and XRP price prediction ahead of U.S. employment report for February

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BBP/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":108.9825,"timestamp":1787688000000,"preClose":106.906,"halted":0,"volume":6580,"hourTrading":{"tag":"盘后","latestPrice":108.9825,"preClose":108.9825,"latestTime":"16:10 EDT","volume":7,"amount":763.37247,"timestamp":1787688604788,"change":0,"changeRate":0,"amplitude":0.002271},"delay":0,"changeRate":0.01942360578452094,"floatShares":1100004,"shares":1100004,"eps":0,"marketStatus":"Post-Mkt","change":2.0765,"latestTime":"08-25 16:44:09 EDT","open":108.98,"high":109.26,"low":108.82,"amount":717337,"amplitude":0.004116,"askPrice":163.75,"askSize":200,"bidPrice":106.74,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":106.906,"sharesOutstanding":600004,"nav":107.357,"aum":118092783.16,"bidAskSpread":0.002259,"postHourTrading":{"tag":"盘后","latestPrice":108.9825,"preClose":108.9825,"latestTime":"16:10 EDT","volume":7,"amount":763.37247,"timestamp":1787688604788,"change":0,"changeRate":0,"amplitude":0.002271},"volumeRatio":0.614643,"impliedVol":0.2424,"impliedVolPercentile":0.6614},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1100004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.614643,"shares":1100004,"dividePrice":0,"high":109.26,"amplitude":0.004116,"preClose":106.906,"low":108.82,"week52Low":66.88,"pbRate":"--","week52High":109.945,"institutionHeld":0,"latestPrice":108.9825,"committee":-0.99005,"eps":0,"divideRate":0,"volume":6580,"delay":0,"ttmEps":0,"open":108.98,"prevYearClose":79.9149,"prevWeekClose":107.47,"prevMonthClose":93.8672,"prevQuarterClose":96.2686,"fiveDayClose":103.4785,"twentyDayClose":97.6934,"sixtyDayClose":86.5827},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649938286","title":"ImageneBio appoints Matt Robbins as general counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938286?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:16","pubTimestamp":1783430160,"startTime":"0","endTime":"0","summary":"ImageneBio (IMA) announced the appointment of Matt Robbins as general counsel, effective July 7. Robbins joins the clinical-stage biotechnology com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/imagenebio-appoints-matt-robbins-as-general-counsel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/imagenebio-appoints-matt-robbins-as-general-counsel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BK4588","BBP","SYNB","AGNG","BK4007","FWD","RSPH","IBB","JDOC","XT","BK4585","FHLC","BBC","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","CHAT","IBB","BK1173","BBP","BK4588","AGIX","PBE","VTHR","QTOC","SBIO","GSKH","LFSC","BK1161","BK1535","BK4585","GDOC","ARTY","03378","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649212640","title":"Novartis agrees to acquire Myricx Bio for up to $1.5B","url":"https://stock-news.laohu8.com/highlight/detail?id=2649212640","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649212640?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:30","pubTimestamp":1783330213,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that it has entered into an agreement to acquire Myricx Bio, a privately held UK-based biotechnology company developing a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-agrees-to-acquire-myricx-bio-for-up-to-1-5b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-agrees-to-acquire-myricx-bio-for-up-to-1-5b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","IE0009355771.USD","BK4007","FWD","BBP","BK4588","IBB","LU0070302665.USD","BK4532","JDOC","LU0320765489.SGD","MEDX","XT","BK4578","LU0211331839.USD","SYNB","IE00BJJMRZ35.SGD","NVS","RSPH","AGNG","IE00BJT1NW94.SGD","PPH","FHLC","IE0002141913.USD","IE00B2B36J28.USD","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649596643","title":"Bio-Gene Technology to Hold Virtual Extraordinary General Meeting in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2649596643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649596643?lang=en_us&edition=fundamental","pubTime":"2026-07-06 12:57","pubTimestamp":1783313831,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Ltd., the ASX-listed biotechnology company, is convening an ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-to-hold-virtual-extraordinary-general-meeting-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-to-hold-virtual-extraordinary-general-meeting-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BGT","BBP","AGNG","IBB","SYNB","BK4588","BK4585","FHLC","JDOC","RSPH","XT","FWD","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161303","title":"How FDA Priority Review for First-in-Class LGMD Drug BBP-418 Could Impact BridgeBio Pharma (BBIO) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161303","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641161303?lang=en_us&edition=fundamental","pubTime":"2026-06-05 01:20","pubTimestamp":1780593617,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma announced that the FDA previously accepted and granted Priority Review to its New Drug Application for oral BBP-418 in LGMD2I/R9, setting a PDUFA target action date of November 27, 2026, without planning an advisory committee meeting.\nIf approved, BBP-418 would be the first therapy for LGMD2I/R9 and any limb-girdle muscular dystrophy, potentially qualifying BridgeBio for a Priority Review Voucher and opening up further rare disease development paths.\nWe’ll now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bbio/bridgebio-pharma/news/how-fda-priority-review-for-first-in-class-lgmd-drug-bbp-418","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bbio/bridgebio-pharma/news/how-fda-priority-review-for-first-in-class-lgmd-drug-bbp-418","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","BK4585","ISBC","BBP","BK4211","BK4139","LABU","BK4588","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638001639","title":"Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2638001639","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638001639?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:16","pubTimestamp":1779916591,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Buy rating on BridgeBio Pharma, with a price target of $98.00. Sean Laaman...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-lifts-bridgebio-price-target-to-98-as-bbp418-becomes-core-growth-driver-following-strong-phase-3-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-lifts-bridgebio-price-target-to-98-as-bbp418-becomes-core-growth-driver-following-strong-phase-3-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638639953","title":"BridgeBio Wins FDA Priority Review for BBP-418 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638639953","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638639953?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:00","pubTimestamp":1779915620,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma ( ($BBIO) ) just unveiled an update. On May 27, 2026, BridgeBio Pharma announced that the U.S. Food and Drug Administration accept...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bridgebio-wins-fda-priority-review-for-bbp-418-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bridgebio-wins-fda-priority-review-for-bbp-418-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638915500","title":"BridgeBio announces FDA acceptance, priority review of BBP-418 NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2638915500","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638915500?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:17","pubTimestamp":1779884262,"startTime":"0","endTime":"0","summary":"BridgeBio (BBIO) announced the FDA has accepted for filing its new drug application, or NDA, with Priority Review for oral BBP-418 for the treatmen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-announces-fda-acceptance-priority-review-of-bbp-418-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-announces-fda-acceptance-priority-review-of-bbp-418-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBIO","LABU","BBP","BK4585","BK4588","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638021595","title":"BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2638021595","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638021595?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:30","pubTimestamp":1779881400,"startTime":"0","endTime":"0","summary":"- Accepted for Priority Review with PDUFA target action date of November 27, 2026, and poised to launch upon approval; being granted Priority Review by the FDA reiterates the serious unmet need for tr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301817/0/en/BridgeBio-Announces-FDA-Acceptance-and-Priority-Review-of-NDA-for-BBP-418-for-LGMD2I-R9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU","BK4081","BBP","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623762312","title":"BridgeBio submits BBP-418 NDA to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2623762312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623762312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:56","pubTimestamp":1774871788,"startTime":"0","endTime":"0","summary":"BridgeBio (BBIO) announced the submission of its new drug application to the FDA for oral BBP-418 for the treatment of individuals living with limb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-submits-bbp-418-nda-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-submits-bbp-418-nda-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BBIO","BK4139","BK4585","BK4505","BK4588","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623916312","title":"BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2623916312","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623916312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":"- Comprehensive submission includes interim Phase 3 FORTIFY data demonstrating BBP-418’s rapid, consistent treatment effect and favorable safety profile, with statistically significant and clinically ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264527/0/en/BridgeBio-Submits-NDA-to-FDA-for-BBP-418-for-Individuals-Living-with-LGMD2I-R9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BBP","EMA","BK4588","BK4081","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618274899","title":"BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2618274899","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618274899?lang=en_us&edition=fundamental","pubTime":"2026-03-12 02:00","pubTimestamp":1773252000,"startTime":"0","endTime":"0","summary":"- Phase 3 FORTIFY interim analysis results presented in a late-breaking oral presentationat MDA highlight the broad and consistent efficacy of BBP-418 across key clinical endpoints and prespecified su","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3254081/0/en/BBP-418-Demonstrates-Consistent-Efficacy-and-Favorable-Safety-Profile-in-Phase-3-FORTIFY-Interim-Analysis-in-LGMD2I-R9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617551184","title":"Solana and XRP price prediction ahead of U.S. employment report for February","url":"https://stock-news.laohu8.com/highlight/detail?id=2617551184","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617551184?lang=en_us&edition=fundamental","pubTime":"2026-03-05 15:52","pubTimestamp":1772697128,"startTime":"0","endTime":"0","summary":"Solana and XRP are holding key technical levels as traders prepare for the release of the February U.S. employment report, a major macro event that could influence risk sentiment across financial markets, including cryptocurrencies.Solana and XRP traders are watching the February U.S. employment report, a key indicator that could shape expectations for Federal Reserve policy and risk appetite.SOL is stabilizing near $91 with accumulation indicators improving, suggesting buyers are gradually returning after February’s sell-off.XRP is trading around $1.42, with momentum indicators pointing to weakening bearish pressure and a potential move toward resistance if macro conditions turn favorable.Investors closely watch the U.S. nonfarm payrolls report because strong labor market data could reinforce expectations that the Federal Reserve will keep interest rates elevated for longer.Conversely, weaker data may strengthen the case for rate cuts later this year, potentially boosting demand for r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/solana-and-xrp-price-prediction-us-employment-report/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/solana-and-xrp-price-prediction-us-employment-report/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["XRP","BBP","SOL.USD.HKCC","SOLT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":113,"code":"91000000","status":"200"}]}}